Imidazo[1,2-a]pyridines. Part 2: SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors
| Autor: | Byth, Kate F.1, Culshaw, Janet D.1, Green, Stephen1, Oakes, Sandra E.1, Thomas, Andrew P. andrew.p.thomas@astrazeneca.com |
|---|---|
| Zdroj: | Bioorganic & Medicinal Chemistry Letters. May2004, Vol. 14 Issue 9, p2245. 4p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|
Full Text from ScienceDirect